ALMAJECT
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 27 Jan 2026)
What this means for you
Registered since 14 Apr 2020. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 14 Apr 2030: the §8 & §9 renewal).
Record
- Serial number
- 88046319
- Registration number
- 6034506
- Mark type
- Word mark
- Filed
- 20 Jul 2018
- Published for opposition
- 18 Dec 2018
- Registered
- 14 Apr 2020
- Next maintenance filing
- §8 & §9 renewal, due by 14 Apr 2030 (grace period to 14 Oct 2030)
- Attorney of record
- GREGG A. PARADISE
Goods and services
- Class 005 — Pharmaceuticals: Injectable pharmaceuticals for treatment of fungal infections, metastatic tumors, cancers, side effects caused by chemotherapy, moderate to severe pain, hypertension, bacterial infections, and bleeding cessation; pharmaceutical preparations, namely, injectable antineoplastic agents, iron chelating agents, sedatives, and muscle relaxants
Owner
- Almaject, Inc., Morristown, NJ
- Almaject, Inc., Pine Brook, NJ
- Almaject, Inc., Pine Brook, NJ
Prosecution history
- 27 Jan 2026 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 27 Jan 2026 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 26 Jan 2026 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 24 Oct 2025 — TEAS SECTION 8 & 15 RECEIVED
- 14 Apr 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 19 Mar 2025 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 12 Mar 2025 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 31 Jul 2020 — CORRECTION UNDER SECTION 7 - PROCESSED
- 20 Jul 2020 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 29 May 2020 — TEAS SECTION 7 REQUEST RECEIVED
- 14 Apr 2020 — REGISTERED-PRINCIPAL REGISTER
- 13 Mar 2020 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 12 Mar 2020 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 27 Feb 2020 — STATEMENT OF USE PROCESSING COMPLETE
- 06 Feb 2020 — USE AMENDMENT FILED